Evaluating the Effectiveness of an Adjunct Therapy in Dogs with Osteosarcoma
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Researchers will investigate how osteosarcoma spreads, in the hopes of finding new treatment targets.